Menu Search

Denmark

OMX Copenhagen 20Last 5 days
Last price1,482.27
S&P GSCILast 5 days
Last price427.41

DKK overview

PairLatest rateToday's change1 year change
DKKGBP0.1195
GBP		-0.000009 / -0.01%0.0066 / 5.81%
Today
0.1108Feb 18 20200.1271Mar 19 2020
DKKEUR0.1344
EUR		0.00 / 0.00%0.0006 / 0.46%
Today
0.133Mar 09 20200.1347Dec 21 2020
DKKUSD0.1636
USD		0.00 / 0.00%0.0152 / 10.21%
Today
0.1424Mar 23 20200.166Jan 06 2021
DKKJPY16.98
JPY		0.00 / 0.00%0.6717 / 4.12%
Today
15.33May 06 202017.14Jan 07 2021
DKKAUD0.212
AUD		0.00 / 0.00%-0.0049 / -2.26%
Today
0.2094Jan 14 20210.265Mar 19 2020
DKKCAD0.2082
CAD		-0.0001 / -0.05%0.0132 / 6.77%
Today
0.1909Feb 19 20200.2146Jul 31 2020
DKKCNY1.06
CNY		0.00 / 0.00%-0.0327 / 3.47%
Today
1.01Feb 19 20201.12Jul 31 2020
DKKCHF0.1448
CHF		0.00 / 0.00%0.0011 / 0.79%
Today
0.1405Mar 09 20200.1472Jan 01 2021

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Denmark in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of Dec 16 2020.

Market movers

Constituents of the OMX Copenhagen 20 with the highest percent gain over one day.
ListingLastChangeVolume
GN Store Nord A/SGN:CPH483.80
DKK		+8.50
+1.79%		302.23k
Coloplast A/SCOLO B:CPH916.00
DKK		+14.00
+1.55%		216.70k
Tryg A/STRYG:CPH204.40
DKK		+2.80
+1.39%		616.47k
Pandora A/SPNDORA:CPH630.00
DKK		+6.00
+0.96%		178.66k
Orsted A/SORSTED:CPH1,253.50
DKK		+11.50
+0.93%		541.20k
Royal Unibrew A/SRBREW:CPH628.40
DKK		+3.40
+0.54%		85.03k
Demant A/SDEMANT:CPH239.80
DKK		+1.20
+0.50%		303.16k
Novo Nordisk A/SNOVO B:CPH444.50
DKK		+0.65
+0.15%		1.80m
Genmab A/SGMAB:CPH2,643.00
DKK		+3.00
+0.11%		126.10k
Data delayed at least 15 minutes, as of Jan 22 2021 15:58 GMT.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.